The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,

CompletedOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

August 20, 2022

Study Completion Date

March 20, 2024

Conditions
Fatigue Syndrome, ChronicBone TumorQuality of Life
Interventions
OTHER

assessment scales (BFI, QLQ, TESS)

the patient's Fatigue will be measured during the treatment period with antiblastic drugs and part of the followup period. To this end the BFI scale validated in Italian will be used (Mendoza et al 1999; Catania et al, 2013) which includes 9 items with a score for each of 0 to 10 and a consequent total score from 0 to 90. The measurement will take place in 4 times: the day of enrollment, 6 months, 12 months and 24 months after enrollment.the quality of life of patients measured by the EORTC QLQ C-30 scale (Aaronson et al, 1993) and the level of autonomy measured by the TESS scale (Davis et al, 1996) in 4 steps: the enrollment day , at 6 months, at 12 months and at 24 months from enrollment.

Trial Locations (1)

40139

Paola Coluccino, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT04104750 - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor, | Biotech Hunter | Biotech Hunter